Skip to main content

Advertisement

Log in

Relationship of Medication Management Test-Revised (MMT-R) Performance to Neuropsychological Functioning and Antiretroviral Adherence in Adults with HIV

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

While performance-based tests of everyday functioning offer promise in facilitating diagnosis and classification of HIV-associated neurocognitive disorders (HAND), there remains a dearth of well-validated instruments. In the present study, clinical correlates of performance on one such measure (i.e., Medication Management Test—Revised; MMT-R) were examined in 448 HIV+ adults who were prescribed antiretroviral therapy. Significant bivariate relationships were found between MMT-R scores and demographics (e.g., education), hepatitis C co-infection, estimated premorbid IQ, neuropsychological functioning, and practical work abilities. MMT-R scores were not related to HIV disease severity, psychiatric factors, or self-reported adherence among participants with a broad range of current health status. However, lower MMT-R scores were strongly and uniquely associated with poorer adherence among participants with CD4 T cell counts <200. In multivariate analyses, MMT-R scores were predicted by practical work abilities, estimated premorbid functioning, attention/working memory, learning, and education. Findings provide overall mixed support for the construct validity of the MMT-R and are discussed in the context of their clinical and research implications for evaluation of HAND.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Brew BJ. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS. 2004;18(Suppl 1):S75–8.

    PubMed  CAS  Google Scholar 

  2. Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3–16.

    Article  PubMed  CAS  Google Scholar 

  3. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8:136–42.

    Article  PubMed  Google Scholar 

  4. Robertson KR, Smurzynski M, Parsons TD, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;21:1915–21.

    Article  PubMed  Google Scholar 

  5. Heaton RK, Marcotte TD, Mindt MR, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10:317–31.

    Article  PubMed  Google Scholar 

  6. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–99.

    Article  PubMed  CAS  Google Scholar 

  7. Blackstone K, Moore DJ, Franklin DR, et al. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc. 2012;18(1):79–88.

    Article  PubMed  CAS  Google Scholar 

  8. Albert SM, Weber CM, Todak G, et al. An observed performance test of medication management ability in HIV: relation to neuropsychological status and medication outcomes. AIDS Behav. 1999;3:121–8.

    Article  Google Scholar 

  9. Albert SM, Flater SR, Clouse R, et al. Medication management skill in HIV: I. Evidence for adaptation of medication management strategies in people with cognitive impairment. II. Evidence for a pervasive lay model of medication efficacy. AIDS Behav. 2003;7(3):329–38.

    Article  PubMed  Google Scholar 

  10. Benedict RH, Mezhir JJ, Walsh K, Hewitt RG. Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Arch Clin Neuropsychol. 2000;15(6):535–44.

    PubMed  CAS  Google Scholar 

  11. Waldrop-Valverde D, Jones DL, Jayaweera D, Gonzalez P, Romero J, Ownby RL. Gender differences in medication management capacity in HIV infection: the role of health literacy and numeracy. AIDS Behav. 2009;13(1):46–52.

    Article  PubMed  Google Scholar 

  12. Woods SP, Moran LM, Carey CL, et al. Prospective memory in HIV infection: is “remembering to remember” a unique predictor of self-reported medication management? Arch Clin Neuropsychol. 2008;23:257–70.

    Article  PubMed  Google Scholar 

  13. Hinkin CH, Castellon SA, Durvasula RS, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59:1944–50.

    Article  PubMed  CAS  Google Scholar 

  14. Woods SP, Dawson MS, Weber E, et al. Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory. J Intl Neuropsycholl Soc. 2009;15:42–52.

    Article  CAS  Google Scholar 

  15. World Health Organization. Priority Interventions HIV/AIDS prevention, treatment and care in the health sector. Geneva: WHO; 2010.

    Google Scholar 

  16. Anand P, Springer SA, Copenhaver MM, Altice FL. Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav. 2010;14(6):1213–26.

    Article  PubMed  Google Scholar 

  17. Ettenhofer ML, Foley J, Castellon SA, Hinkin CH. Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology. 2010;74(15):1217–22.

    Article  PubMed  Google Scholar 

  18. Diehl M, Willis SL, Schaie KW. Everyday problem solving in older adults: observational assessment and cognitive correlates. Psychol Aging. 1995;10(3):478–91.

    Article  PubMed  CAS  Google Scholar 

  19. Waldrop-Valverde D, Osborn CY, Rodriguez A, Rothman RL, Kumar M, Jones D. Numeracy skills explain racial differences in HIV medication management. AIDS Behav. 2010;14(4):799–806.

    Article  PubMed  Google Scholar 

  20. Waldrop-Valverde D, Jones DL, Gould F, Kumar M, Ownby RL. Neurocognition, health-related reading literacy, and numeracy in medication management for HIV infection. AIDS Patient Care STDS. 2010;24(8):477–84.

    Article  PubMed  Google Scholar 

  21. Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded Halstead–Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Odessa: Psychological Assessment Resources; 2004.

    Google Scholar 

  22. Thames AD, Kim MS, Becker BW, et al. Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol. 2011;33(2):200–9.

    Article  PubMed  Google Scholar 

  23. Heaton RK, Clifford DB, Woods SP, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology. 2010;75:2087–96.

    Article  PubMed  Google Scholar 

  24. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12:255–66.

    Article  PubMed  CAS  Google Scholar 

  25. Wilkinson GS. Wide Range Achievement Test. 3rd ed. Wilmington: Wide Range; 1993.

    Google Scholar 

  26. Heaton RK, Miller SW, Taylor MJ, Grant I. Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz: Psychological Assessment Resources, Inc; 2004

  27. Heaton RK, Taylor MJ, Manly JJ. Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In: Tulsky D, et al., editors. Clinical interpretation of the WAIS-III and WMS-III. San Diego: Academic Press; 2002. p. 183–210.

    Google Scholar 

  28. Kongs SK, Thompson LL, Iverson GL, Heaton RK. Wisconsin card sorting test-64 card version: professional manual. Lutz: Psychological Assessment Resources Inc.; 2000.

    Google Scholar 

  29. Reitan RM. Manual for administration of neuropsychological test batteries for adults and children. Tucson: Reitan Neuropsychology Laboratories, Inc.; 1979.

    Google Scholar 

  30. Corporation Psychological. WAIS-III and WMS-III technical manual. San Antonio: Author; 1997.

    Google Scholar 

  31. Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exper Neuropsychol. 2004;26:759–78.

    Article  Google Scholar 

  32. Valpar International Corporation. Computerized assessment (COMPASS). Tucson: Author; 1992.

    Google Scholar 

  33. U.S. Department of Labor. Dictionary of occupational titles. 4th ed. Washington: U.S. Government Printing Office; 1991.

    Google Scholar 

  34. Janikowski TP, Bordieri JE, Musgrave JR. Construct validation of the academic achievement and general educational development subtests of the microcomputer evaluation screening and assessment (MESA). Voc Eval Work Adjust Bull. 1990;23:11–6.

    Google Scholar 

  35. Stoelting C. A study of the construct validity of the MESA. Voc Eval Work Adjust Bull. 1990;23:85–91.

    Google Scholar 

  36. World Health Organization. Composite international diagnostic interview, version 2.1. Geneva: WHO; 1997.

  37. Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory-II. San Antonio: Psychological Corporation; 1996.

    Google Scholar 

  38. Basso MR, Bornstein RA. Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12-months. J Clin Exper Neuropsychol. 2000;22:208–18.

    Article  CAS  Google Scholar 

  39. Satz P, Morgenstern H, Miller EN, et al. Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the multicenter AIDS cohort study (MACS). J Acquir Immune Defic Syndr. 1993;66(5):503–11.

    Google Scholar 

  40. Pereda M, Ayuso-Mateos JL, Gomez Del Barrio A, et al. Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS. Psychol Med. 2000;30:205–17.

    Article  PubMed  CAS  Google Scholar 

  41. Waldrop-Valverde D, Jones DL, Weiss S, Kumar M, Metsch L. The effects of low literacy and cognitive impairment on medication adherence in HIV-positive injecting drug users. AIDS Care. 2008;20(10):1202–10.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by NIH contract N01 MH2205 (CHARTER; PI: I. Grant). Participating sites include: Johns Hopkins University (J. McArthur); Mt. Sinai School of Medicine (S. Morgello & D. Simpson); University of California, San Diego (J.A. McCutchan); University of Texas Medical Branch, Galveston (B. Gelman); University of Washington, Seattle (A. C. Collier & C. Marra); Washington University, St. Louis (D. Clifford).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven Paul Woods.

Additional information

The study is conducted for the CHARTER Group.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patton, D.E., Woods, S.P., Franklin, D. et al. Relationship of Medication Management Test-Revised (MMT-R) Performance to Neuropsychological Functioning and Antiretroviral Adherence in Adults with HIV. AIDS Behav 16, 2286–2296 (2012). https://doi.org/10.1007/s10461-012-0237-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-012-0237-7

Keywords

Navigation